Opsens (OTCMKTS:OPSSF) had its target price increased by Raymond James from $2.50 to $2.75 in a report released on Thursday, The Fly reports. The firm presently has an “outperform” rating on the stock. Raymond James’ target price would suggest a potential upside of 88.36% from the company’s current price.
Separately, Royal Bank of Canada upped their price target on shares of Opsens from $1.50 to $2.00 and gave the company an “outperform” rating in a research report on Thursday, January 14th.
Shares of OTCMKTS:OPSSF traded up $0.04 during midday trading on Thursday, reaching $1.46. The company had a trading volume of 302,814 shares, compared to its average volume of 91,471. The company has a fifty day simple moving average of $1.37 and a two-hundred day simple moving average of $1.03. Opsens has a 1-year low of $0.41 and a 1-year high of $1.85.
Opsens Inc develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in two segments, Medical and Industrial. The Medical segment primarily focuses on physiological measurement, such as FFR and dPR in the coronary artery stenosis market; and supplies a range of miniature optical sensors to measure pressure and temperature used in integrated applications in other medical devices, as well as licenses its optical sensor technology.
Featured Article: Understanding Specialty Certificates of Deposit
Receive News & Ratings for Opsens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opsens and related companies with MarketBeat.com's FREE daily email newsletter.